KORRO
LIVE

Serial Number

98305479

Owner

Korro Bio, Inc.

Attorney

Tiffany D. Gehrke

Filing Date

Dec 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

KORRO Trademark

Serial Number: 98305479

KORRO is a trademark filed by Korro Bio, Inc. on December 8, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Korro Bio, Inc. (12 trademarks)

Suite 6-401
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

December 8, 2023

Registration Date

Not Registered

Published for Opposition

August 20, 2024

Goods & Services

Pharmaceutical research and development; Pharmaceutical research and development in the fields of gene therapies, gene editing, drug discovery and development; Pharmaceutical research and development incorporating artificial intelligence; Pharmaceutical research and development incorporating genetic learning; Scientific and industrial research; Scientific and industrial research incorporating artificial intelligence; Scientific and industrial research in the field of gene therapies, gene editing, drug discovery and development incorporating genetic learning; Medical and scientific research in the field of pharmaceuticals, genetics, gene editing, and genetic diseases

Custom manufacture of biomedical compounds comprised of nucleotide polymers and biomedical compounds comprised of ribonucleic acid polymers all for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders for others; Custom manufacture and processing of human cells for medical purposes for others; Treatment of therapeutic cells for others, namely, pharmacological treatment and processing of therapeutic cells to modify their function for therapeutic purposes

Pharmaceutical preparations for the treatment of genetic diseases; Pharmaceutical products for cell therapy to treat genetic diseases; Medical and scientific research in the field of pharmaceuticals, genetics, gene editing, and genetic diseases

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 4, 2026 EXRA
SOU EXTENSION 3 GRANTED
Apr 3, 2026 EX3G
SOU EXTENSION 3 FILED
Apr 3, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 3, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 2 GRANTED
Sep 4, 2025 EX2G
SOU EXTENSION 2 FILED
Sep 4, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 4, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 9, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 8, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 8, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 8, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 3, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 3, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 3, 2025 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 15, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 16, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 16, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 16, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 16, 2024 CNEA
ASSIGNED TO EXAMINER
Jul 9, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 7, 2024 NWOS
NEW APPLICATION ENTERED
Dec 8, 2023 NWAP